Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro …
Post-acute neurological sequelae of COVID-19 affect millions of people worldwide, yet little
data is available to guide treatment strategies for the most common symptoms. We …
data is available to guide treatment strategies for the most common symptoms. We …
Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in COVID-19 patients: a narrative review
Introduction Migraine pharmacological therapies targeting calcitonin gene-related peptide
(CGRP), including monoclonal antibodies and gepants, have shown clinical effect and …
(CGRP), including monoclonal antibodies and gepants, have shown clinical effect and …
[HTML][HTML] Acute and Preventive Treatment of COVID-19-Related Headache: A Series of 100 Patients
D García-Azorín, C García-Ruiz, Á Sierra-Mencía… - Life, 2024 - mdpi.com
To describe the need and effectiveness of acute and preventive medications in a series of
100 consecutive patients referred due to COVID-19-related headaches. Patients were aged …
100 consecutive patients referred due to COVID-19-related headaches. Patients were aged …
COVID-19-Impfung-assoziierte anhaltende Kopfschmerzen: Wie einordnen?
A Straube, R Ruscheweyh, T Klonowski - Der Schmerz, 2023 - Springer
Zusammenfassung Einleitung Im Rahmen einer akuten COVID-19-Infektion (Coronavirus
SARS-CoV‑2 Infektion) treten in 10–60% der Patient: innen Kopfschmerzen auf, die Tage …
SARS-CoV‑2 Infektion) treten in 10–60% der Patient: innen Kopfschmerzen auf, die Tage …
Nociplastic pain in COVID-19
Altered nociception without nerve damage leading to pain without fulfilling the nociceptive or
neuropathic pain criteria is called nociplastic pain, which is associated with sleep, memory …
neuropathic pain criteria is called nociplastic pain, which is associated with sleep, memory …
Management of Headache Related to COVID-19
D Garcia-Azorin, J Díaz de Terán… - Headache Disorders in …, 2023 - Springer
Headache is a disabling symptom, both during and after the acute phase of coronavirus
disease 2019 (COVID-19). Most patients require acute medication to alleviate headache …
disease 2019 (COVID-19). Most patients require acute medication to alleviate headache …